Lekha Babu M.D Ltd. — Flossmoor, Illinois

Lekha Babu M.D Ltd. is a clinical research site located in Flossmoor, Illinois, United States 60422.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Lekha Babu M.D Ltd. has participated in 1 clinical trials.

Therapeutic areas: Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Flossmoor

Browse all research sites in Illinois · View every site in Flossmoor

• University of Chicago Flossmoor
• Healthcare Research Network II, LLC
• Healthcare Research Network - Chicago
• GSK Investigational Site
• UChicago Medicine at Ingalls - Flossmoor
• Healthcare Research Network
• Novartis Investigative Site
• South Suburban Neurology
• Aptinyx Clinical Site
• Healthcare Research Network - Flossmoor IL
• Joliet Oncology-Hematology Associates, Ltd.
• Lexicon Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lekha Babu M.D Ltd.?

Lekha Babu M.D Ltd. has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lekha Babu M.D Ltd. conducted?

Lekha Babu M.D Ltd. has 1 clinical trials on record. Their work covers Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant.

Is Lekha Babu M.D Ltd. accredited by Crixeo Clinical Trials?

Lekha Babu M.D Ltd. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lekha Babu M.D Ltd.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.